Ravindre Panchia to Delayed-Action Preparations
This is a "connection" page, showing publications Ravindre Panchia has written about Delayed-Action Preparations.
Connection Strength
0,039
-
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial. PLoS Med. 2018 11; 15(11):e1002690.
Score: 0,039